European Respiratory Journal · 1991 · 40 citations · 10 references
PharmacyPharmacokineticsPharmacologyDrug DeliveryPulmonary Function TestingPulmonologyAerosol TherapyInhalation Dosage FormsInhalation Drug DeliveryLung DepositionNebulizer SystemsNebulizer TherapyAcquired Immunodeficiency SyndromeAlveolar DepositionInhaled AdministrationJet NebulizersLung Deposition MeasurementNebulized Drug DepositionNebulizer AdministrationOropharyngeal Deposition
Aerosolised pentamidine 300 mg in 5 or 6 ml solution was administered via 8 different nebuliser systems to 12 patients with acquired immunodeficiency syndrome. Using 99mTc human serum albumin as an indirect marker for pentamidine, pulmonary, extrapulmonary (gastric and oropharyngeal) and alveolar deposition of pentamidine were measured using a gamma camera. Side effects (visual analogue scales) and changes in lung function associated with each treatment were also quantified. Deposition was completed more rapidly with the ultrasonic than the jet nebulisers. Mean total pulmonary depositions (mg +/- SEM) were Respirgard II, 6.1 +/- 0.5; Centimist, 7.3 +/- 1.0, System 22 Mizer, 14.3 +/- 2.1; System 22 Mizer with particle separator; 4.5 +/- 0.4; System 22 Mizer with Optimist 2, 6.3 +/- 0.9; Fisoneb, 6.0 +/- 1.2; Pentasonic (Portasonic); 4.6 +/- 0.9; Samsonic, 2.9 +/- 0.4. Differences between the nebulisers for peripheral lung and alveolar deposition reflected this pattern. Side effects scores were largest with System 22 Mizer, Pentasonic (Portasonic), and Fisoneb, and these produced the greatest oropharyngeal and gastric deposition. The largest reductions in lung function were associated with System 22 Mizer. A 300 mg dose of pentamidine nebulised via Respirgard II is known to be effective prophylaxis for Pneumocystis carinii pneumonia when given once monthly. Our results show that equivalent pulmonary deposition can be produced by other nebulisers. System 22 Mizer gives over twice the deposition associated with Respirgard II, and used with a pentamidine dose of 150 mg is likely to produce an adequate lung dose for prophylaxis. This nebuliser, however, is associated with more marked side effects.
10
The effects of preferential deposition of histamine in the human airway.
R. Ruffin, Myrna Dolovich, Ronald K. Wolff et al. · PubMed · 1978 · 101 citations
PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA BY INHALED PENTAMIDINE
JeffreyA. Golden, Harry Hollander, David Chernoff et al. · The Lancet · 1989 · 96 citations